# A Phase 1 Study of WVE-007 in Adults Living With Overweight or Obesity

> **NCT06842186** · PHASE1 · RECRUITING · sponsor: **Wave Life Sciences Ltd.** · enrollment: 136 (estimated)

## Conditions studied

- Obesity and Overweight

## Interventions

- **DRUG:** WVE-007

## Key facts

- **NCT ID:** NCT06842186
- **Lead sponsor:** Wave Life Sciences Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842186, "A Phase 1 Study of WVE-007 in Adults Living With Overweight or Obesity". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06842186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*